Reference
Li T, et al. Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutations. Thoracic Cancer 12: 2924-2932, No. 21, Nov 2021. Available from: URL: http://doi.org/10.1111/1759-7714.14156
Rights and permissions
About this article
Cite this article
Afatinib. Reactions Weekly 1912, 21 (2022). https://doi.org/10.1007/s40278-022-17724-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-17724-2